OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Mary Sano

1 Projects | 1 Researchers | $178,801 Invested

2000

Icahn School of Medicine at Mount Sinai

Mary Sano, PhD

Effect of High-Dose Supplements on Blood Homocyteine in Alzheimer's Disease

  • Funding Amount: $178,801
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed